一种新型超短效非去极化神经肌肉阻滞药GW280430A(AV430A)
A Novel Ultrashort - Acting Nondepolarizing Neuromuscular Blocking Drug GW 280430A (AV430A)
摘要
GW280430A具有起效快、作用时间短、不蓄积、不良反应少等特点,是目前最有前途的可取代琥珀胆碱的非去极化肌松 药。
出处
《国外医学（麻醉学与复苏分册）》
2005年第5期295-297,共3页
Foreign Medical Sciences(Anesthesilolgy and Resuscitation)
参考文献16
-
1White PF. Rapacuronium:Why did it fail as a replacement for succinylcholine? Br J Anaesth ,2002,88(2):163-165.
-
2Caldwell JE. The continuing search for a succinylcholine replacement. Anesthesiology, 2004,100(4 ) :763 - 764.
-
3Boros EE, Samano V, Ray JA, et al. Neuromuscular blocking activity and therapeutic potential of mixed -tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys. J Med Chem ,2003,46(2) :2502 -2515.
-
4Savarese JJ, Belmont MR, Hashim MA, et al. Preclinical pharmacology of GW280430A(AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium. Anesthesiology, 2004,100(4):835-845.
-
5Boros EE, Bigham EC, Boswell GE, et al. Bis- and mixed -tetrahydroisoquinolinium chlorofumarates: new ultra- short acting nondepolarizing neuromuscular blockers. J Med Chem, 1999,42(2) :206 -209.
-
6Moore EW, Hunter J M. The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth, 2001, 87(6): 6912 -6925.
-
7Belmont MR, Lien CA, Tjan J, et al. Clinical pharmacology of GW280430A in humans . Anesthesiology, 2004,100(4): 768 -773.
-
8Levy J, Pitts M, Thanopoulos A, et al. The effects of rapacuronium on histamine release and hemodynamics in adult patients undegoing general anesthesia. Ancsth Analg,1999,89(2) :290 -295.
-
9Dhonneur G, Kirov K, Slavov V, et al. Effects of an intubating dose of succinylcholine and rocuronium on the larynx and diaphragm:An electromyographic study in humans. Anesthesiology,1999,90(4):951 -955.
-
10Lien CA, Belmont MR, Gurvitch DI, et al. Spontaneous and edrophonium augmented recovery from GW280430A - induced neuromuscular block.Anesthesiology , 1999,91 ( Suppl ): A1017.
-
1Jorgen Viby-Mogensen,张京范.神经肌肉阻滞药——最新进展[J].国外医学（麻醉学与复苏分册）,1991,12(3):166-168.
-
2田阿勇,王俊科.女性肥胖因素对维库溴铵肌松作用的影响[J].临床麻醉学杂志,2003,19(9):568-569. 被引量：6
-
3徐积恩.神经肌肉阻滞药的开发近况[J].化学医药工业信息,1996,12(3):8-10.
-
4岑黎明,江泽龙.肌松药的配伍应用[J].国外医学（麻醉学与复苏分册）,1997,18(4):207-209. 被引量：5
-
5李友清,卢健芳,郭曲练.国产和进口维库溴铵临床药效比较[J].湖南医科大学学报,2002,27(6):572-572.
-
6潘晨宇,金善爱,段立波,孙旭芳.吸入麻醉药对非去极化肌松药在全身麻醉中的作用[J].吉林医学,2012,33(7):1458-1459.
-
7上官王宁,连庆泉,陈小玲,李军,Fang Gao Smith.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395-396. 被引量：18
-
8汤军.非去极化肌松药的联合应用[J].国外医学（麻醉学与复苏分册）,1997,18(4):203-206. 被引量：4
-
9吕慧,马鹤,朱卓,潘晨宇,潘振祥.新型非去极化肌松药—米库氯铵[J].中国实验诊断学,2013,17(7):1359-1361. 被引量：25
-
10姬雅君,王恒林,周文文,孙树峥.顺苯磺酸阿曲库铵在腰椎结核手术中的肌松作用[J].临床麻醉学杂志,2015,31(4):409-409. 被引量：9
